Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1192 participants
OBSERVATIONAL
2017-12-01
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: Patients treated for CRC between 1998 and 2011 at the Klinik Favoriten in Vienna, Austria were analyzed in this retrospective single-center cohort analysis concerning OS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Age, Body Mass Index and Tumor Sidedness in Metastatic Colorectal Cancer
NCT04543019
Relationship Between Lymph Node Ratio and Survival Rate in Preoperative Chemoradiation Rectal Cancer Patients
NCT04096118
Evaluation of Surgical Complications and DFS in Obese Rectal Cancer Patients
NCT06056726
Lymph Node Yield in Colon Cancer Resection Specimens
NCT04260139
Survival of Patients With a Reduction in the Number of Lymph Nodes in Rectal Cancer After Neoadjuvant Chemoradiotherapy
NCT04456283
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Colon cancer patients
Retrospective data analysis of the subgroup of patients suffering from colon carcinoma
no intervention, retrospective data analysis
not applicable, retrospective data analysis
Rectal cancer patients
Retrospective data analysis of the subgroup of patients suffering from rectal carcinoma
no intervention, retrospective data analysis
not applicable, retrospective data analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention, retrospective data analysis
not applicable, retrospective data analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* treated at the Klinik Favoriten between 1998 and 2011
* elective or acute surgical setting
* curative intent
* older than 18 years
Exclusion Criteria
* treated before 1998 or after 2011
* palliative intent
* younger than 18 years
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Klinik Favoriten
OTHER
Salzkammergut Klinikum Vöcklabruck
NETWORK
Klinikum Floridsdorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Tamara Braunschmid
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tamara Braunschmid, MD
Role: PRINCIPAL_INVESTIGATOR
Klinik Floridsdorf
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik Floridsdorf
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK 18-002-VK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.